{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T22:49:58Z","timestamp":1792622998681,"version":"4.5.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T00:00:00Z","timestamp":1621382400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T00:00:00Z","timestamp":1621382400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1007\/s10067-021-05757-w","type":"journal-article","created":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T02:02:25Z","timestamp":1621389745000},"page":"4225-4232","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Is there a potential dual effect of denosumab for treatment of osteoporosis and sarcopenia?"],"prefix":"10.1007","volume":"40","author":[{"given":"Yasser El","family":"Miedany","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maha El","family":"Gaafary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias","family":"Toth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Osama","family":"Hegazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia El","family":"Aroussy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waleed","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samah","family":"Almedany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie","family":"Nasr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sami","family":"Bahlas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5010-2959","authenticated-orcid":false,"given":"Salwa","family":"Galal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Egyptian Academy of Bone Health, Metabolic Bone Diseases","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,19]]},"reference":[{"issue":"2","key":"5757_CR1","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1093\/rheumatology\/keaa755","volume":"60","author":"MA Clynes","year":"2021","unstructured":"Clynes MA, Gregson CL, Bruy\u00e8re O, Cooper C, Dennison EM (2021) Osteosarcopenia: where osteoporosis and sarcopenia collide. Rheumatology (Oxford) 60(2):529\u2013537. https:\/\/doi.org\/10.1093\/rheumatology\/keaa755","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"5757_CR2","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1177\/0884533616680354","volume":"32","author":"SJ Peterson","year":"2017","unstructured":"Peterson SJ, Mozer M (2017) Differentiating sarcopenia and cachexia among patients with cancer. Nutr Clin Pract 32(1):30\u201339","journal-title":"Nutr Clin Pract"},{"issue":"10","key":"5757_CR3","doi-asserted-by":"publisher","first-page":"2781","DOI":"10.1007\/s00198-017-4151-8","volume":"28","author":"HP Hischfeld","year":"2017","unstructured":"Hischfeld HP, Kinsella R, Duque G (2017) Osteosarcopenia: where bone, muscle, and fat collide. Osteoporos Int 28(10):2781\u20132790","journal-title":"Osteoporos Int"},{"issue":"12","key":"5757_CR4","doi-asserted-by":"publisher","first-page":"2660","DOI":"10.1111\/jgs.16165","volume":"67","author":"P Steven","year":"2019","unstructured":"Steven P, Ebrahim B, Sara V, Ben K, Gustavo D (2019) Effect of denosumab on falls, muscle strength, and function in community-dwelling older adults. J Am Geriatr Soc 67(12):2660\u20132661","journal-title":"J Am Geriatr Soc"},{"issue":"1","key":"5757_CR5","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/ageing\/afy169","volume":"48","author":"AJ Cruz-Jentoft","year":"2019","unstructured":"Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruy\u00e8re O, Cederholm T, Cooper C, Landi F, Rolland Y, Sayer AA, Schneider SM, Sieber CC, Topinkova E, Vandewoude M, Visser M, Zamboni M (2019) Writing group for the European Working Group on Sarcopenia in Older People 2 (EWGSOP2), and the Extended Group for EWGSOP2. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 48(1):16\u201331","journal-title":"Age Ageing"},{"key":"5757_CR6","doi-asserted-by":"crossref","unstructured":"- Hernlund E, Svedbom A, Iverg\u00e5rd M, Compston J, Cooper C, Stenmark J, et al. Osteoporosis in the European Union: medical management, epidemiology and economic burden. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch Osteoporos. 2013;8(1-2):136.","DOI":"10.1007\/s11657-013-0136-1"},{"issue":"3","key":"5757_CR7","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1002\/jcsm.12567","volume":"11","author":"B Kirk","year":"2020","unstructured":"Kirk B, Zanker J, Duque G (2020) Osteosarcopenia: epidemiology, diagnosis, and treatment-facts and numbers. J Cachexia Sarcopenia Muscle 11(3):609\u2013618. https:\/\/doi.org\/10.1002\/jcsm.12567","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"5","key":"5757_CR8","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1359\/jbmr.080109","volume":"23","author":"MS Ominsky","year":"2008","unstructured":"Ominsky MS et al (2008) RANKL inhibition with osteoprotegerin increases bone strength by improving cortical and trabecular bone architecture in ovariectomized rats. J Bone Miner Res 23(5):672\u2013682","journal-title":"J Bone Miner Res"},{"issue":"1","key":"5757_CR9","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s40478-018-0533-1","volume":"6","author":"S S\u00e9bastien","year":"2018","unstructured":"S\u00e9bastien S, Antoine B, Sabrina B, Anteneh A, Dounia H, Laetitia M, Daniel G et al (2018) Genetic deletion of muscle RANK or selective inhibition of RANKL is not as effective as full-length OPG-fc in mitigating muscular dystrophy. Acta Neuropathol Commun 6(1):31","journal-title":"Acta Neuropathol Commun"},{"key":"5757_CR10","doi-asserted-by":"crossref","unstructured":"S\u00e9bastien S et al. Receptors Clin Investig. 2016; 3(2): e1323-1\u2013e1323-6","DOI":"10.15845\/jaf.v1i1.1323"},{"key":"5757_CR11","first-page":"1","volume":"130","author":"N Bonnet","year":"2019","unstructured":"Bonnet N, Bourgoin L, Biver E (2019) RANKL inhibition improves muscle strength and insulin sensitivity and restores bone mass. J Clin Invest 130:1","journal-title":"J Clin Invest"},{"key":"5757_CR12","doi-asserted-by":"crossref","unstructured":"- El Miedany et al. Falls Risk Assessment Score (FRAS). J Clin Gerontology and Geriatrics 2011; 21\u201326.","DOI":"10.1016\/j.jcgg.2011.01.002"},{"key":"5757_CR13","doi-asserted-by":"publisher","first-page":"M85","DOI":"10.1093\/geronj\/49.2.M85","volume":"49","author":"JM Uralnik","year":"1994","unstructured":"Uralnik JM, Simonsick EM, Ferrucci L et al (1994) A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol 49:M85\u2013M94","journal-title":"J Gerontol"},{"key":"5757_CR14","doi-asserted-by":"publisher","unstructured":"14 - El Miedany, Y, Abu-Zaid, MH, El Gaafary, M, Hasab El Naby MM, Fathi N, Saber HG, et al (2021) Egyptian consensus on treat-to-target approach for osteoporosis: a clinical practice guideline from the Egyptian Academy of bone health and metabolic bone diseases. Egypt Rheumatol Rehabil. 48:5. https:\/\/doi.org\/10.1186\/s43166-020-00056-9","DOI":"10.1186\/s43166-020-00056-9"},{"key":"5757_CR15","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1056\/NEJMoa0809493","volume":"361","author":"SR Cummings","year":"2009","unstructured":"Cummings SR, Martin JS, McClung MR (2009) Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med 361:756\u2013765","journal-title":"N Engl J Med"},{"key":"5757_CR16","doi-asserted-by":"publisher","first-page":"2781","DOI":"10.1007\/s00198-017-4151-8","volume":"28","author":"HP Hirschfeld","year":"2017","unstructured":"Hirschfeld HP, Kinsella R, Duque G (2017) Osteosarcopenia: where bone, muscle, and fat collide. Osteoporos Int 28:2781\u20132790","journal-title":"Osteoporos Int"},{"issue":"4","key":"5757_CR17","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.ajpath.2015.01.006","volume":"185","author":"SS Dufresne","year":"2015","unstructured":"Dufresne SS, Dumont NA, Bouchard P, Lavergne \u00c9, Penninger JM, Frenette (2015) Osteoprotegerin protects against muscular dystrophy. J Am J Pathol 185(4):920\u2013926","journal-title":"J Am J Pathol"},{"key":"5757_CR18","first-page":"e13231","volume":"3","author":"SS Dufresne","year":"2016","unstructured":"Dufresne SS, Boulanger-Piette A, Boss\u00e9 S (2016) Physiological role of receptor activator nuclear factor-kB (RANK) in denervation-induced muscle atrophy and dysfunction. Receptors Clin Investig 3:e13231\u2013e13236","journal-title":"Receptors Clin Investig"},{"issue":"1","key":"5757_CR19","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1359\/jbmr.090716","volume":"25","author":"DL Kendler","year":"2010","unstructured":"Kendler DL, Roux C, Benhamou CL et al (2010) Effects of denosumab on bone mineral density and bone turnover in postmenopausal women transitioning from alendronate therapy. J Bone Miner Res 25(1):72\u201381","journal-title":"J Bone Miner Res"},{"key":"5757_CR20","doi-asserted-by":"crossref","unstructured":"- Mohammed Qaisi, Jamie Hargett, Matthew Loeb, Jeffrey Brown, Ronald Caloss, \"Denosumab related osteonecrosis of the jaw with spontaneous necrosis of the soft palate: report of a life threatening case\", Case Reports in Dentistry 2016; 2016, Article ID 5070187.","DOI":"10.1155\/2016\/5070187"},{"issue":"16","key":"5757_CR21","doi-asserted-by":"publisher","first-page":"3082","DOI":"10.1016\/j.ejca.2012.08.002","volume":"48","author":"A Lipton","year":"2012","unstructured":"Lipton A, Fizazi K, Stopeck AT et al (2012) Superiority of denosumab to zoledronic acid for prevention of skeletal-related events: a combined analysis of 3 pivotal, randomised, phase 3 trials. Eur J Cancer 48(16):3082\u20133092","journal-title":"Eur J Cancer"},{"key":"5757_CR22","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/s00223-018-0394-4","volume":"103","author":"AW Popp","year":"2018","unstructured":"Popp AW, Varathan N, Buffat H et al (2018) Bone mineral density changes after 1 year of denosumab discontinuation in postmenopausal women with long-term denosumab treatment for osteoporosis. Calcif Tissue Int 103:50\u201354","journal-title":"Calcif Tissue Int"},{"key":"5757_CR23","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1097\/GME.0b013e31827cabca","volume":"20","author":"JH Park","year":"2013","unstructured":"Park JH, Park KH, Cho SH, Choi YS, Seo SK, Lee BS et al (2013) Concomitant increase in muscle strength and bone mineral density with decreasing IL-6 levels after combination therapy with alendronate and calcitriol in postmenopausal women. Menopause 20:747\u2013753","journal-title":"Menopause"},{"issue":"1","key":"5757_CR24","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.afos.2015.07.005","volume":"1","author":"A Haradaa","year":"2015","unstructured":"Haradaa A, Itoa S, Matsuia Y, Sakaia Y, Takemuraa M, Tokudab H, HidacT SH (2015) Effect of alendronate on muscle mass: investigation in patients with osteoporosis. Osteoporosis and Sarcopenia 1(1):53\u201358","journal-title":"Osteoporosis and Sarcopenia"},{"key":"5757_CR25","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1111\/jphp.12171","volume":"66","author":"K Shiomi","year":"2014","unstructured":"Shiomi K, Nagata Y, Kiyono T, Harada A, N, (2014) Hashimoto differential impact of the bisphosphonate alendronate on undifferentiated and terminally differentiated human myogenic cells. J Pharm Pharmacol 66:418\u2013427","journal-title":"J Pharm Pharmacol"},{"key":"5757_CR26","doi-asserted-by":"publisher","first-page":"2692","DOI":"10.1172\/JCI118722","volume":"97","author":"GA Rodan","year":"1996","unstructured":"Rodan GA, Fleisch HA (1996) Bisphosphonates: mechanisms of action. J Clin Invest 97:2692\u20132696","journal-title":"J Clin Invest"},{"key":"5757_CR27","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1001\/archinte.160.1.77","volume":"160","author":"MC Nevitt","year":"2000","unstructured":"Nevitt MC, Thompson DE, Black D, Rubin SR, Ensrud K, Yates AJ et al (2000) Effect of alendronate on limited activity days and bed-disability days caused by back pain in postmenopausal women with existing vertebral fractures. Arch Intern Med 160:77\u201385","journal-title":"Arch Intern Med"},{"key":"5757_CR28","doi-asserted-by":"publisher","first-page":"123","DOI":"10.2147\/CIA.S9696","volume":"5","author":"H Kawate","year":"2010","unstructured":"Kawate H, Ohnaka K, Adachi M, Kono S, Ikematsu H, Matsuo H et al (2010) Alendronate improves QOL of postmenopausal women with osteoporosis. Clin Interv Aging 5:123\u2013131","journal-title":"Clin Interv Aging"},{"key":"5757_CR29","doi-asserted-by":"crossref","unstructured":"- I. Marantes, S.J. Achenbach, E.J. Atkinson, S. Khosla, L.J. Melton 3rd, S. Amin (2011). Is vitamin D a determinant of muscle mass and strength? J Bone Min Res; 26: 2860\u20132871.","DOI":"10.1002\/jbmr.510"},{"issue":"Suppl. 1","key":"5757_CR30","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1111\/ggi.12222","volume":"14","author":"S Ito","year":"2014","unstructured":"Ito S, Harada A, Kasai T, Sakai Y, Takemura M, Matsui Y et al (2014) Use of alfacalcidol in osteoporotic patients with low muscle mass might increase muscle mass: an investigation using a patient database. Geriatr Gerontol Int 14(Suppl. 1):122\u2013128","journal-title":"Geriatr Gerontol Int"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-021-05757-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-021-05757-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-021-05757-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,24]],"date-time":"2021-09-24T22:01:50Z","timestamp":1632520910000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-021-05757-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,19]]},"references-count":30,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["5757"],"URL":"https:\/\/doi.org\/10.1007\/s10067-021-05757-w","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,19]]},"assertion":[{"value":"8 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All listed authors have seen and approved the final version of the manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Yasser El-Miedany, Maha El Gaafary, Mathias Toth, Mohamed Osama Hegazi, Nadia El Aroussy, Waleed Hassan, Samah Almedany, Annie Nasr, Sami Bahlas, and Salwa Galal declare that they have no conflict of interest and have full control of all primary data and that they agree to allow the journal to review their data if requested.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}